Ipsen S.A. (IPSEY)
OTCMKTS · Delayed Price · Currency is USD
35.99
+0.88 (2.49%)
Dec 9, 2025, 9:30 AM EST
Ipsen Market Cap
Ipsen has a market cap or net worth of $11.8 billion as of December 10, 2025. Its market cap has increased by 24.87% in one year.
Market Cap
11.80B
Enterprise Value
11.24B
Revenue
4.42B
Ranking
n/a
PE Ratio
22.44
Stock Price
$35.99
Market Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 2.08B to 11.80B, an increase of 466.81%. That is a compound annual growth rate of 9.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 11.62B | 22.58% |
| Dec 31, 2024 | 9.48B | -3.79% |
| Dec 29, 2023 | 9.85B | 11.34% |
| Dec 30, 2022 | 8.85B | 17.52% |
| Dec 31, 2021 | 7.53B | 9.75% |
| Dec 31, 2020 | 6.86B | -6.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.88M |
| Glass House Brands | 513.14M |
| CytoDyn | 415.92M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 364.04M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |